| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/29/2011 | CN102107002A Compound trimebutine maleate composition and preparation method thereof |
| 06/29/2011 | CN102107001A Application of LXR nuclear receptor agonist in treatment and prevention of autoimmune diseases |
| 06/29/2011 | CN102107000A Application of cholecystokinin octapeptide in pharmacy |
| 06/29/2011 | CN102106828A Thymalfasin sustained-release microsphere preparation and preparation method thereof |
| 06/29/2011 | CN102106820A Epidermal growth factor nanolipid carrier preparation and preparation method thereof |
| 06/29/2011 | CN102106540A Freckle-removal beautifying biological composition |
| 06/29/2011 | CN101658497B Dual drug-loading composite microsphere and preparation method thereof |
| 06/29/2011 | CN101440126B Acquisition and use of homing polypeptide with targeting specificity related to tumor and metastases thereof |
| 06/29/2011 | CN101396563B Chitose derivates using octreotide as target ligand and use thereof in medicament |
| 06/29/2011 | CN101233231B Anti-obesity agent and anti-obesity food |
| 06/29/2011 | CN101049502B Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/29/2011 | CN101036055B Detection of elevated levels of Her-2/neu protein on circulating cancer cells and treatment |
| 06/28/2011 | US7968767 Antifreeze proteins isolated from forage grasses and methods for their use |
| 06/28/2011 | US7968707 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/28/2011 | US7968696 Viral interleukin-6 |
| 06/28/2011 | US7968692 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid |
| 06/28/2011 | US7968688 Antibodies that bind to the C35 polypeptide |
| 06/28/2011 | US7968683 Factor IXa crystals, related complexes and methods |
| 06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
| 06/28/2011 | US7968679 Purified rhIGF-I/rhIGFBP-3 complexes and their method of manufacture |
| 06/28/2011 | US7968678 Glial mitogenic factors, their preparation and use |
| 06/28/2011 | US7968676 Tumor antigen protein SART-3 and tumor antigen peptides thereof |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968527 Inhibition of FGF signaling |
| 06/28/2011 | US7968526 Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer |
| 06/28/2011 | US7968520 Chimeric DRG11-responsive (DRAGON) polypetides |
| 06/28/2011 | US7968518 Use of modified cyclosporins for the treatment of HCV disorders |
| 06/28/2011 | US7968517 Method for treating withdrawal symptoms due to opiate consumption |
| 06/28/2011 | US7968516 Treatment of multiple sclerosis and other autoimmune diseases by use of calpin inhibitors |
| 06/28/2011 | US7968515 Protein S protects the nervous system from injury |
| 06/28/2011 | US7968514 Pharmaceutical composition for treating or preventing ovarian cancer |
| 06/28/2011 | US7968513 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof |
| 06/28/2011 | US7968512 Conjugates that contain the homeodomain of antennapedia |
| 06/28/2011 | US7968511 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis |
| 06/28/2011 | US7968340 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 06/28/2011 | US7968337 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 06/28/2011 | US7968311 Using transgenic cells for propagation of heterologous proteins; bioreactors |
| 06/28/2011 | US7968307 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 06/28/2011 | US7968303 Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1) |
| 06/28/2011 | US7968301 Method of modulating Sost binding to LRP |
| 06/28/2011 | US7968298 attenuated DNA viruses which increases production of chemokines |
| 06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 06/28/2011 | US7968123 Complexing agents for compositions containing inclusion complexes |
| 06/28/2011 | US7968106 ABFB-1 gene of penicillium funiculosum |
| 06/28/2011 | US7968104 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 06/28/2011 | US7968103 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 06/28/2011 | US7968100 Surface proteins from coagulase-negative staphylococci and Staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies |
| 06/28/2011 | US7968099 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 06/28/2011 | US7968098 HLA-A24-binding KIF-derived peptide |
| 06/28/2011 | US7968097 Identification of Hla-A2-presented T-cell epitopes derived from the oncofoetal antigen-immature laminin receptor protein and uses thereof |
| 06/28/2011 | US7968091 Methods and compositions to regulate iron metabolism |
| 06/28/2011 | US7968090 Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer |
| 06/28/2011 | US7968089 Proteoglycan degrading mutants for the treatment of CNS |
| 06/28/2011 | US7968087 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 06/28/2011 | US7968085 Hydrogel formulations |
| 06/28/2011 | CA2641667C Composition for optimizing muscle performance during exercise |
| 06/28/2011 | CA2558835C Rapid acting drug delivery compositions |
| 06/28/2011 | CA2544432C Stable pharmaceutical composition comprising granulocyte-colony stimulating factor |
| 06/28/2011 | CA2506603C Nutritional compositions |
| 06/28/2011 | CA2470656C Corticotropin releasing factor 2 receptor agonists |
| 06/28/2011 | CA2460026C Porous ceramic composite bone grafts |
| 06/28/2011 | CA2445841C Uses of chemically-modified cholinesterases for detoxification of organophosphorus compounds |
| 06/28/2011 | CA2414772C Prevention and treatment of alzheimer's disease |
| 06/28/2011 | CA2393042C Antithrombotic compound |
| 06/28/2011 | CA2380305C Streptogramin derivatives, production thereof and compositions containing the same |
| 06/28/2011 | CA2332179C Uses of dna-pk |
| 06/28/2011 | CA2324301C Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
| 06/28/2011 | CA2315976C Serine protease inhibitors |
| 06/28/2011 | CA2259944C Melanoma associated peptide analogues and vaccines against melanoma |
| 06/28/2011 | CA2222747C Dna sequence and encoded mammary-specific breast cancer protein |
| 06/28/2011 | CA2190293C Method of cancer treatment by p53 protein control |
| 06/28/2011 | CA1341617C Inhibin isolated from ovarian follicular fluid |
| 06/23/2011 | WO2011075725A1 Methods and compositions related to clot-binding compounds |
| 06/23/2011 | WO2011075678A1 Specific inhibitors and active site probes for legumain |
| 06/23/2011 | WO2011075623A1 One - phase gel compos ition compri s ing phos pholi pids |
| 06/23/2011 | WO2011075611A1 Compositions and methods for non-invasive treatment of chronic complication of diabetes |
| 06/23/2011 | WO2011075606A2 Hyperglycosylated polypeptide variants and methods of use |
| 06/23/2011 | WO2011075605A2 Hyperglycosylated interferon variants and methods of use |
| 06/23/2011 | WO2011075539A2 Treatment of obesity or diabetes with bile acid sequestrants |
| 06/23/2011 | WO2011075516A2 Active scaffolds for on-demand drug and cell delivery |
| 06/23/2011 | WO2011075471A2 Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders |
| 06/23/2011 | WO2011075393A2 Glucagon/glp-1 receptor co-agonists |
| 06/23/2011 | WO2011075056A1 Protein composition |
| 06/23/2011 | WO2011075035A1 A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy |
| 06/23/2011 | WO2011074992A1 Treatment composition and method |
| 06/23/2011 | WO2011074881A2 Substances for inhibiting expression of genes for sensitivity to allergic disorders |
| 06/23/2011 | WO2011074608A1 Prophylactic or therapeutic agent for chronic hepatitis c |
| 06/23/2011 | WO2011073918A2 Peptides as modulators of fprl1 and/or fprl2 |
| 06/23/2011 | WO2011073739A1 Methods, pharmaceutical compositions and kits for use in the treatment of adult t-cell leukemia/lymphoma |
| 06/23/2011 | WO2011073207A1 Use of a neurofilament peptide for the treatment of glioma |
| 06/23/2011 | WO2011072991A1 Peptide |
| 06/23/2011 | WO2011072875A1 Fusion polypeptides and their use for prevention and treatment of cancer |
| 06/23/2011 | WO2011072596A1 Soluble collagen and preparation method and use thereof |
| 06/23/2011 | WO2011072501A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant |
| 06/23/2011 | WO2011072487A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 06/23/2011 | WO2011072484A1 Target and medicaments for treatment of brain injuries |
| 06/23/2011 | WO2011072483A1 Compositions and methods for controlling proliferation and differentiation cells |
| 06/23/2011 | WO2011072482A1 Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells |
| 06/23/2011 | WO2011072370A1 Hcv combination therapy |
| 06/23/2011 | WO2011072336A1 Antiviral agents |